Cargando…
Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
Prostate cancer is the most common type of cancer and the leading cause of cancer deaths among men in many countries. Preventing progression is a major concern for prostate cancer patients on active surveillance, patients with recurrence after radical therapies, and patients who acquired resistance...
Autores principales: | Hayashi, Takuji, Fujita, Kazutoshi, Matsushita, Makoto, Nonomura, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721573/ https://www.ncbi.nlm.nih.gov/pubmed/31408948 http://dx.doi.org/10.3390/cancers11081153 |
Ejemplares similares
-
Application of Anti-Inflammatory Agents in Prostate Cancer
por: Hatano, Koji, et al.
Publicado: (2020) -
Obesity, Inflammation, and Prostate Cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2019) -
Influence of Diet and Nutrition on Prostate Cancer
por: Matsushita, Makoto, et al.
Publicado: (2020) -
The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
por: Fujita, Kazutoshi, et al.
Publicado: (2023) -
Role of Androgen Receptor in Prostate Cancer: A Review
por: Fujita, Kazutoshi, et al.
Publicado: (2019)